Irdin Tablets 4 mg (Irsozogladin Maleate)

Adult dose

1) Gastric ulcer (Adults) Administer 4mg of irsogladine maleate orally once daily. 2) Improvement of gastric mucosal lesions (erosion, bleeding, redness, and edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis (Adults) Administer 4mg of irsogladine maleate orally in 1∼2 divided doses daily.

This drug contains lactose, so it should not be used in patients with genetic diseases that cause lactose intolerance. Various side effects such as liver dysfunction, constipation, rash, itching, diarrhea, etc. may occur, so if unusual symptoms appear, you should consult a healthcare professional immediately. Elderly patients may have decreased physical function, so they should start with a smaller dosage and carefully monitor their condition when taking. Women who are pregnant or may become pregnant should use this drug only if the benefits outweigh the risks, as safety during pregnancy is not established. Breastfeeding women should avoid taking this medication if possible, as it may pass into breast milk, and if unavoidable, it is advisable to discontinue breastfeeding. In children, caution should be exercised in using this drug as its safety has not been sufficiently established. This drug should be kept out of reach of children and should not be transferred to other containers, as this may degrade its quality.

• Abnormal liver function
• elevated ALT (GPT)
• elevated AST (GOT)
• constipation
• rash
• pruritus
• diarrhea
• elevated ALP
• nausea
• vomiting

This medication may be sensitive to air or moisture, so it should be stored in a sealed container. It is recommended to maintain a storage temperature between 1 to 30 degrees Celsius at room temperature.

Appearance

White round tablet

Package unit

30 tablets/bottle, 100 tablets/bottle